BioGaia Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Theresa Agnew

Chief executive officer

SEK 6.8m

Total compensation

CEO salary percentage	19.4%
CEO tenure	less than a year
CEO ownership	n/a
Management average tenure	3.2yrs
Board average tenure	3.2yrs

Recent management updates

Recent updates

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Dec 13

BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Nov 28

CEO Compensation Analysis

How has Theresa Agnew's remuneration changed compared to BioGaia's earnings?
Date	Total Compensation	Salary	Company Earnings
Mar 31 2024	n/a	n/a	SEK 371m
Dec 31 2023	SEK 7m	SEK 1m	SEK 365m

Compensation vs Market: Theresa's total compensation ($USD642.27K) is about average for companies of similar size in the Swedish market ($USD770.69K).

Compensation vs Earnings: Insufficient data to compare Theresa's compensation with company performance.

CEO

Theresa Agnew (58 yo)

less than a year

Tenure

SEK 6,750,250

Compensation

Ms. Theresa P. Agnew serves as President of BioGaia AB (publ) since September 2023 and serves as its Chief Executive Officer since 25 September 2023. She is a global business leader with consumer healthcar...

Leadership Team

Name	Position	Tenure	Compensation	Ownership
Peter Rothschild	Founder & Chairman	6.3yrs	SEK 1.33m	no data
Theresa Agnew	CEO & President	less than a year	SEK 6.75m	no data
Alexander Kotsinas	Executive VP & CFO	4.7yrs	SEK 3.07m	0.0030% SEK 369.5k
Ludvig Milesson	Chief Operating Officer	1.3yrs	no data	0.0012% SEK 154.3k
Gianfranco Grompone	Chief Scientific Officer and VP of Research & Development	4.5yrs	no data	no data
Caroline Mofors	Chief Legal Officer	1.5yrs	no data	no data
Linda Hagglund	Vice President of Marketing	3.2yrs	no data	0.00019% SEK 23.6k
Angelika Kjelldorff	Chief HR Officer	5.5yrs	no data	0.00050% SEK 62.2k
Sebastian Heimfors	VP & Chief Commercial Officer	2.3yrs	no data	no data
Jonathan Gromark	Sustainability Manager	no data	no data	no data
Keitaro Nomura	MD & President of BioGaia Japan Inc.	no data	no data	no data

3.2yrs

Average Tenure

52yo

Average Age

Experienced Management: BIOG B's management team is considered experienced (3.2 years average tenure).

Board Members

Name	Position	Tenure	Compensation	Ownership
Peter Rothschild	Founder & Chairman	6.3yrs	SEK 1.33m	no data
David E. Dangoor	Independent Deputy Board Chairman	21.5yrs	SEK 590.00k	1.73% SEK 215.6m
Vesa Koskinen	Director	1.2yrs	SEK 275.00k	no data
Barbro Friden	Director	1.2yrs	SEK 275.00k	0.00050% SEK 62.2k
Anthon Jahreskog	Independent Director	9.2yrs	SEK 405.00k	0.0040% SEK 497.6k
Vanessa Rothschild	Director	4.2yrs	SEK 275.00k	0.00016% SEK 19.9k
Benedicte Flambard	Director	2.2yrs	SEK 275.00k	no data
Outi Armstrong	Director	1.2yrs	SEK 275.00k	no data

3.2yrs

Average Tenure

54yo

Average Age

Experienced Board: BIOG B's board of directors are considered experienced (3.2 years average tenure).

BioGaia Management

Management criteria checks 3/4

Key information

Recent management updates

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Less than half of directors are independent

Independent Director recently bought kr51k worth of stock

Vice President of RA & Legal recently bought kr103k worth of stock

Recent updates

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)

Third quarter 2021 earnings released

Price target increased to kr533

Second quarter 2021 earnings released: EPS kr2.71 (vs kr4.56 in 2Q 2020)

Consensus forecasts updated

BioGaia AB (publ) (OM:BIOG B) acquired remaining 8% stake in MetaboGen AB for SEK 11.4 million.

Vice President of RA & Legal recently bought kr103k worth of stock

First quarter 2021 earnings released

Biogaia AB (Publ) Approves Dividend

Upcoming dividend of kr3.41 per share

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year